Lunai Bioworks

LNAI on Nasdaq. Market value $1m.

Watch this stockFree. We tell you when something changes.

Should I look at this?

Look carefully before going further

Why it could be worth it

Nothing stands out yet.

Read the warning sign in its own filings

This is not advice.

Compare with another stock

Who owns it

None of the long-term investors we follow own it. 15 funds in all.

Jun '26
Largest holders overall

From 13F filings for the quarter ended 30 June 2026.

Big holders and activists

2 investors own more than 5%.

  • Laksya Ventures Inc.
    Passive investor
    at least 9.6%
    (filed with 1 related holder)
    Since 7 July 2025
  • Hansen Hans Christian
    Passive investor
    at least 9.4%
    (filed with 2 related holders)
    Since 22 May 2026
  • William Anderson Wittekind
    Sold down below 5%
    Since 13 October 2026

From Schedule 13D and 13G filings: anyone owning more than 5% must file one.

What insiders did

No insider bought or sold on the open market in the last 12 months.

From Form 4 filings: insiders must report trades in their own company's shares within two days.

Warning signs in its filings

Problems the company itself reported to the SEC, in its own words.

3 serious warning signs in Lunai Bioworks’ filings.

We look for five warning signs: doubt it can keep going, weak checks on its own accounts, a notice that its past accounts can't be relied on, a change of auditor, and one customer bringing in a big share of sales. We don't check lawsuits, investigations or debt yet.

We checked the auditor's report, internal controls, restatement notices, auditor changes and big customers in the 10-K filed 13 Oct 2026, plus 1 later 8-K.

  • Doubt it can keep going

    Serious

    The company or its auditor warned it may not have enough money to last the next year.

    “As a result of our financial condition and other factors described herein, there is substantial doubt about our ability to continue as a going concern.”
    Show the full paragraph
    Our consolidated financial statements as of June 30, 2026, have been prepared under the assumption that we will continue as a going concern for the next twelve months. As of June 30, 2026, we had cash and cash equivalents of $1,713,653 and an accumulated deficit of $514,025,049. We do not believe that our cash and cash equivalents are sufficient for the next twelve months. As a result of our financial condition and other factors described herein, there is substantial doubt about our ability to continue as a going concern. Our ability to continue as a going concern will depend on our ability to obtain additional funding, as to which no assurances can be given. We continue to analyze various alternatives, including potentially obtaining debt or equity financings or other arrangements. Our future success depends on our ability to raise capital. We cannot be certain that raising additional capital, whether through selling additional debt or equity securities or obtaining a line of credit or other loan, will be available to us or, if available, will be on terms acceptable to us. If we issue additional securities to raise funds, these securities may have rights, preferences, or privileges senior to those of our Common Stock, and our current shareholders may experience dilution. If we are unable to obtain funds when needed or on acceptable terms, we may be required to curtail our current development programs, cut operating costs, forgo future development and other opportunities, or even terminate our operations.

    From the 10-K filed 13 October 2026, Item 1A. Risk Factors. Read it in the filing

  • Weak checks on its own accounts

    Serious

    The company said its checks on its own accounts did not work at year end. Mistakes could slip into the numbers.

    “Based on that evaluation, management concluded that, as of June 30, 2026, the Company’s internal control over financial reporting was not effective due to a material weakness.’ The material weakness is attributable to the Company not having adequate resources to address complex accounting matters.”
    Show the full paragraph
    Management Annual Report on Internal Control over Financial Reporting Management is responsible for establishing and maintaining adequate internal control over financial reporting for the Company. Management used the criteria set forth in “Internal Control—Integrated Framework (2013)” issued by the Committee of Sponsoring Organizations of the Treadway Commission (“COSO”) to conduct a review of the Company’s internal control over financial reporting. Based on that evaluation, management concluded that, as of June 30, 2026, the Company’s internal control over financial reporting was not effective due to a material weakness.’ The material weakness is attributable to the Company not having adequate resources to address complex accounting matters. Management intends to remediate the material weakness as resources permit, including through the engagement of additional qualified accounting personnel and third-party consultants with appropriate technical accounting expertise, and will monitor the design and operation of the related controls as the Company grows.

    From the 10-K filed 13 October 2026, Item 9A. Controls and Procedures. Read it in the filing

  • Its past accounts can't be relied on

    Serious

    It told the SEC its earlier accounts should no longer be relied on, usually because they contained errors.

    8-K Item 4.02 filed 19 Feb 2025: the company said its earlier financial statements should no longer be relied on.

    From an 8-K filed 19 February 2025: Previously issued accounts should no longer be relied on. Open the filing

A 10-K is the yearly report every US company files with the SEC. An 8-K is a short notice of a big event.

The deep dive

Everything above is arithmetic on public filings. The deep dive reads the last ten years of annual reports, the proxy statements, and the earnings calls, then argues the case the way Buffett, Klarman, and Hohn would, and checks every claim against the source.

  • What the business is worth, as a range, and the margin of safety at today’s price
  • Prices to start buying, buy, and buy hard
  • The three things that would make this a mistake
  • Every number footnoted to the filing it came from

A serious warning sign just appeared in its filings. Read what it says before you buy.

Create a free account to run it

Your first deep dive is free.

What a finished deep dive looks like

Not advice. Numbers on this page come from SEC filings and are updated each night; prices are updated again after the US market closes. The five-year figures are rounded.